<DistDoc action="rep" dist="dist_id" distdocver="05.1" an="WSJO000020180322ee3m002pa" doctype="article"><SelectData><FolderName id="302210958" rl="100">WSJ</FolderName></SelectData><ReplyItem lang="en"><BaseLang value="en" fid="la"/><IPDocId fid="id">81D1D2589406B26C6C6065A677F051B3 SB12695538546930973963904584117271002750320</IPDocId><AccessionNo value="WSJO000020180322ee3m002pa" fid="an"/><Num value="339" fid="wc"/><Date value="20180322" fid="pd"/><Time value="131900" fid="et"/><SrcCode value="wsjo" fid="sc"/><SrcName fid="sn">The Wall Street Journal Online</SrcName><TruncRules><XS value="30"/><S value="56"/><M value="80"/></TruncRules><Title fid="hl"><SectionName fid="se">Markets</SectionName><ColumnName fid="clm">Heard on the Street</ColumnName><Headline fid="hd"><Para lang="en">Durex-Maker Reckitt Avoids $20 Billion Headache; Turning down Pfizer's consumer-health business shows discipline, but leaves Reckitt Benckiser with plenty of work</Para></Headline></Title><Snippet><Para>Having turned down Advil, Reckitt Benckiser needs to find another treatment for the headache of weak growth.</Para><Para>The U.K.-based consumer group, which makes Clearasil acne cream, Durex condoms and Lysol sanitizers, announced late Wednesday that ...</Para></Snippet><Byline fid="by">By Stephen Wilmot </Byline><Credit fid="cr"></Credit><Copyright fid="cy">Copyright 2018 Dow Jones &amp; Company, Inc. All Rights Reserved. </Copyright><CodeSets><CSet fid="co"><Code value="rcol"/><Code value="pfiz"/></CSet><CSet fid="in"><Code value="i951"/><Code value="icnp"/><Code value="inondhg"/><Code value="i257"/><Code value="i2581"/></CSet><CSet fid="re"><Code value="namz"/><Code value="usa"/></CSet><CSet fid="ns"><Code value="mcat"/><Code value="ncolu"/><Code value="ncat"/><Code value="nfact"/><Code value="nfce"/></CSet></CodeSets></ReplyItem><MetadataPT><DocData><DocType value="article" fid="fmt"/><IPDocId fid="id">81D1D2589406B26C6C6065A677F051B3 SB12695538546930973963904584117271002750320</IPDocId><AccessionNo value="WSJO000020180322ee3m002pa" fid="an"/><Num value="339" fid="wc"/><Num value="1661" fid="cc"/><Date value="20180322" fid="pd"/><Date value="20180322" fid="upd"/><Date value="20180322" fid="md"/><Time value="131900" fid="et"/><Time value="131917" fid="upt"/><Time value="133715" fid="mt"/><BaseLang value="en" fid="la"/><Editor value="" fid="rve"/><RevisionNo value="3" fid="rvn"/></DocData><PubData><Restrictor fid="rst"><Code value="FSPNORMAWS0300"/><Code value="WSJO"/><Code value="fspFileId275579661"/><Code value="FUT"/><Code value="CLNTALL"/><Code value="CTGSMFS"/><Code value="CTGWSJ"/><Code value="DEEPWSJP"/><Code value="EN"/><Code value="IBNK"/><Code value="IFINAL"/><Code value="IINV"/><Code value="NAMZ"/><Code value="SFWSJ"/><Code value="TBAC"/><Code value="TBED"/><Code value="TBIZ"/><Code value="TBRK"/><Code value="TDJP"/><Code value="TDJWMNP"/><Code value="TFCDLIC"/><Code value="TFIN"/><Code value="TIAS"/><Code value="TIBMNB"/><Code value="TIMG"/><Code value="TINT"/><Code value="TIOP"/><Code value="TMNB"/><Code value="TMNBUS"/><Code value="TNPS"/><Code value="TNWP"/><Code value="TNWPN"/><Code value="TOPUSA"/><Code value="TSCH"/><Code value="TTRD"/><Code value="TTRK"/><Code value="TUSN"/><Code value="TWMSA"/><Code value="TYAS"/><Code value="TYLA"/><Code value="USA"/><Code value="fspWebpage"/><Code value="djrcef"/><Code value="MPCV1M9M1B1"/><Code value="MPCEnvPROD"/><Code value="MPCDocHashE88E5A3C7A71E7DA"/><Code value="FSPTHINGFINDER"/><Code value="FSPRBC"/><Code value="FSPRBCCO"/><Code value="FSPRBCCOM"/><Code value="FSP2YESCO"/><Code value="FSP2YESCOCOM"/><Code value="FSP2YESCOOC"/><Code value="FSP2YESCOCOMOC"/><Code value="FSPRBCIN"/><Code value="FSP2YESIN"/><Code value="FSPRBCNS"/><Code value="FSP2YESNS"/><Code value="FSPRBCRE"/><Code value="FSP2YESRE"/><Code value="FSP2YESPEOC"/><Code value="FSPRBC591452"/><Code value="FSPRBC808880"/><Code value="FSPRBC818182"/><Code value="FSPRBC845758"/><Code value="FSPRBC852186"/><Code value="FSPRBC857128"/><Code value="FSPRBC857432"/><Code value="FSPRBC857677"/><Code value="FSPRBC861461"/><Code value="FSPRBC861689"/><Code value="FSPRBC861836"/><Code value="FSPRBC861918"/><Code value="FSPRBC861922"/><Code value="MPCCL"/><Code value="MPCJP"/><Code value="MPCKW"/><Code value="MPCKP"/><Code value="MPCESRE"/><Code value="MPCESIN"/><Code value="MPCESNS"/><Code value="FSP2AC"/></Restrictor><IPId value="DJENT" fid="ip"/><PublisherN fid="pub">Dow Jones &amp; Company, Inc.</PublisherN><AttribCode value="WSJO2" fid="atr"/><SrcCode value="WSJO" fid="sc"/><SrcName fid="sn">The Wall Street Journal Online</SrcName><Logo img="wsjoLogo.gif" link="" src="http://logos.factiva.com"/></PubData><CodeSets><CSet fid="co"><Code value="rcol"><CodeD index="no" lang="en">Reckitt Benckiser Group PLC</CodeD><CodeI org="thingfinder" action="add"><CodeA name="db" value="ptf--aboutCo-00004106-20180321-231407.dictionary"/></CodeI><CodeI org="rbc" action="add"><CodeA name="rule" value="857128"/><CodeA name="db" value="prbc---00018571-20180322-025042"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="status" value="active"/></CodeI></Code><Code value="pfiz"><CodeD index="no" lang="en">Pfizer Inc</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="591452"/><CodeA name="db" value="prbc---00018571-20180322-025042"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="status" value="active"/></CodeI></Code></CSet><CSet fid="in"><Code value="i951"><CodeD index="no" lang="en">Health Care/Life Sciences</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="861918"/><CodeA name="db" value="prbc---00018571-20180322-025042"/></CodeI><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="root" value="in:i257"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="nodelevel" value="0"/></CodeI></Code><Code value="icnp"><CodeD index="no" lang="en">Consumer Goods</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="861922"/><CodeA name="db" value="prbc---00018571-20180322-025042"/></CodeI><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="root" value="in:i2581"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="nodelevel" value="0"/></CodeI></Code><Code value="inondhg"><CodeD index="no" lang="en">Nondurable Household Products</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="861836"/><CodeA name="db" value="prbc---00018571-20180322-025042"/></CodeI><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="root" value="in:i2581"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="nodelevel" value="1"/></CodeI></Code><Code value="i257"><CodeD index="no" lang="en">Pharmaceuticals</CodeD><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="root" value="co:pfiz"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="nodelevel" value="1"/></CodeI></Code><Code value="i2581"><CodeD index="no" lang="en">Soap/Cleaning Products</CodeD><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="root" value="co:rcol"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="nodelevel" value="2"/></CodeI></Code></CSet><CSet fid="re"><Code value="namz"><CodeD index="no" lang="en">North America</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="861461"/><CodeA name="db" value="prbc---00018571-20180322-025042"/></CodeI><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="root" value="re:usa"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="nodelevel" value="0"/></CodeI></Code><Code value="usa"><CodeD index="no" lang="en">United States</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="845758"/><CodeA name="db" value="prbc---00018571-20180322-025042"/><CodeA name="rule" value="861689"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="nodelevel" value="1"/></CodeI></Code></CSet><CSet fid="ns"><Code value="mcat"><CodeD index="no" lang="en">Commodity/Financial Market News</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="857677"/><CodeA name="db" value="prbc---00018571-20180322-025042"/><CodeA name="rule" value="857432"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="nodelevel" value="0"/></CodeI></Code><Code value="ncolu"><CodeD index="no" lang="en">Columns</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="808880"/><CodeA name="db" value="prbc---00018571-20180322-025042"/><CodeA name="rule" value="852186"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="status" value="active"/></CodeI></Code><Code value="ncat"><CodeD index="no" lang="en">Content Types</CodeD><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="root" value="ns:mcat"/><CodeA name="root" value="ns:ncolu"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="status" value="active"/></CodeI></Code><Code value="nfact"><CodeD index="no" lang="en">Factiva Filters</CodeD><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="root" value="ns:mcat"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="status" value="active"/></CodeI></Code><Code value="nfce"><CodeD index="no" lang="en">C&amp;E Exclusion Filter</CodeD><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="root" value="ns:mcat"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000998-20180321-161406"/><CodeA name="status" value="active"/></CodeI></Code></CSet></CodeSets><DescTPC fid="de"><DescField fid="ipc">GSK GSK.LN I/HPN M/HCR M/NCY PFE R/NME R/US RB.LN RBGLY UL ULVR.LN </DescField><DescField fid="ipd">WSJ.com WSJ.com Site Search WSJAsia WSJEurope WSJ Japanese Online WSJ-PRO-WSJ.com HST ADVIL CLEARASIL DUREX GLAXO LYSOL PFIZER RECKITT BENCKISER SB126955385469309739639045841172710027503201 Kapoor, Rakesh SYND CODES_REVIEWED Heard on the Street </DescField><DescField fid="ipcns">OMKM </DescField><DescField fid="ipcconame">Reckitt Benckiser Pfizer's </DescField><DescField fid="ipccodj">GSK.LN PFE RB.LN ULVR.LN </DescField></DescTPC></MetadataPT><ArchiveDoc xml:space="preserve"><Article markup="pp0" lang="en" index="field"><HandL fid="hlp"><Title fid="hl"><SectionName fid="se" index="field">Markets</SectionName><ColumnName fid="clm" index="field">Heard on the Street</ColumnName><Headline fid="hd"><Para lang="en">Durex-Maker Reckitt Avoids $20 Billion Headache; Turning down Pfizer's consumer-health business shows discipline, but leaves Reckitt Benckiser with plenty of work</Para></Headline></Title><LeadPara fid="lp"><Para>Having turned down Advil, Reckitt Benckiser needs to find another treatment for the headache of weak growth.</Para><Para>The U.K.-based consumer group, which makes Clearasil acne cream, Durex condoms and Lysol sanitizers, announced late Wednesday that it had ended its pursuit of Pfizer's consumer-health unit. The U.S. health care giant put its nonprescription business, which is expected to <ELink type="webpage" ref="https://www.wsj.com/articles/pfizer-reviews-consumer-healthcare-business-options-could-include-spinoff-or-sale-1507634886">fetch up to $20 billion</ELink>, on the block last October. Reckitt's retreat seemingly leaves the path clear for GlaxoSmithKline, the global leader in branded consumer drugs.</Para></LeadPara></HandL><TailParas fid="td"><Para>Reckitt was most interested in Advil, Pfizer's popular version of ibuprofen, but found Pfizer unwilling to <ELink type="webpage" ref="https://www.wsj.com/articles/reckitt-makeover-clears-way-for-pfizer-bid-1508331531">sell the division in pieces</ELink>. Buying it whole would be a financial stretch, given the debt Reckitt took on in its $16.6 billion acquisition of Mead Johnson last spring.</Para><Para>Many think the U.K. company wouldn't have bought Mead Johnson if it had known Pfizer was ready to sell. Chief Executive Rakesh Kapoor has made no secret of his ambition to move away from kitchen staples toward health care brands, which <ELink type="webpage" ref="https://www.wsj.com/articles/drugstore-favorites-may-be-catching-the-common-consumer-cold-1508149810">arguably face less competition</ELink> from trendy startups and private-label copies than other consumer categories.</Para><Para>The shares, previously down almost a fifth this year, rose Wednesday as fears of a rights issue to fund the megadeal lifted. Reckitt could engineer a further lift by announcing the disposal of underperforming home and hygiene brands. It split these into a separate division in January, prompting speculation they would be sold. Last year, Reckitt got a <ELink type="webpage" ref="https://www.wsj.com/articles/frenchs-mustard-and-heinz-ketchup-not-the-perfect-mix-1491226727">high price for its food brands</ELink>, including French's mustard.</Para><Para>But the only way Mr. Kapoor can sustainably <ELink type="webpage" ref="https://www.wsj.com/articles/is-reckitts-deal-machine-still-up-to-snuff-1519053523">win back investors' trust</ELink> is by reviving the core portfolio of brands. This could prove harder under its lean operating model than for peers like Unilever. Walking away from Pfizer is the easy part.</Para><Para>Write to Stephen Wilmot at <ELink type="webpage" ref="mailto:stephen.wilmot@wsj.com">stephen.wilmot@wsj.com</ELink></Para></TailParas><Byline fid="by" index="field">By Stephen Wilmot </Byline><Credit fid="cr" index="field"></Credit><Contact fid="ct" index="field"></Contact><Notes fid="rf" index="field"></Notes><Art fid="art" index="field"></Art><Copyright fid="cy" index="field">Copyright 2018 Dow Jones &amp; Company, Inc. All Rights Reserved. </Copyright></Article></ArchiveDoc><AdocTOC adoctype="article"><Item size="0" ref="distdoc:archive/ArchiveDoc::Article" type="arttext"></Item><Item size="0" ref="distdoc:archive/InvertText" type="invtext"></Item><Item subtype="primary" size="0" ref="https://www.wsj.com/articles/durex-maker-reckitt-avoids-20-billion-headache-1521724748" type="webpage"></Item></AdocTOC></DistDoc>

